Log in to save to my catalogue

Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine

Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_235986040

Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine

About this item

Full title

Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine

Publisher

Atlanta: NewsRx

Journal title

Biotech Business Week, 2005, p.49

Language

English

Publication information

Publisher

Atlanta: NewsRx

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Norwood Immunology has licensed its immunology intellectual property to TAP Pharmaceutical Products Inc. for commercialization in the United States, utilizing TAP's GnRH analogue, Lupron Depot (leuprolide acetate for depot suspension). This combined initiative is exploring the use of Lupron Depot in regenerating the thymus gland and in turn "reboot...

Alternative Titles

Full title

Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_235986040

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_235986040

Other Identifiers

ISSN

1543-687X

E-ISSN

1543-6861

How to access this item